---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management and improve patient outcomes, today announced the publication of a study validating performance of a novel algorithm designed to integrate the DecisionDx ® -Melanoma gene expression profile (GEP) test with clinicopathologic features (i31-GEP SLNB) to determine sentinel lymph node biopsy (SLNB) positivity risk in patients with cutaneous melanoma."
publishedDateTime: 2021-11-05T21:01:00Z
originalUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
webUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "JxdzqrgoI5t5P0k90UEd8H3FuMkvDo6CTRPwq0kR8v7NTThfE2Vl+YnApAY000KjJ8lk0SxeVOxW4lFwZwqU3Qnot8INn40lalPgIr1puRLAl1m7Ob2I3CDMeXW26+oYlZAHoIhj1qZYhHODoFyT/651Cjpm94Ns/p9Pd/U2pqzdxkalqkHvBVqBn7xmofTj1D0G6pEwbAAe9KOxBqo1+L1apOJVic9n3hAsMB5E1eQN5q5aFWQr2DF4jaCuxnsUHrPSnZwOJxdZTqGEElMK3JsGV09zO8F2ZHXYNlChFj8hq0UR53VXxqAUNy6zCvWSnHfHUGJfv74/0GOuhvjzisifhZPxo8UPA2UeN0gQ1Ng=;tjQBwOrD/h/DRgtsf8ek5A=="
---

